Potassium voltage-gated channel, shaker-related subfamily, member 5, also known asKCNA5 orKv1.5, is aprotein that in humans is encoded by theKCNA5gene.[5]
Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. KCNA5 encodes a member of the potassium channel, voltage-gated, shaker-related subfamily. This member contains six membrane-spanning domains with a shaker-type repeat in the fourth segment. It belongs to the delayed rectifier class, the function of which could restore the restingmembrane potential ofbeta cells after depolarization, thereby contributing to the regulation ofinsulin secretion. This gene isintronless, and the gene is clustered with genesKCNA1 andKCNA6 on chromosome 12.[5] Mutations in this gene have been related to bothatrial fibrillation[6] and sudden cardiac death.[7] KCNA5 are also key players in pulmonary vascular function, where they play a role in setting the resting membrane potential and its involvement during hypoxic pulmonary vasoconstriction.
^Nielsen NH, Winkel BG, Kanters JK, Schmitt N, Hofman-Bang J, Jensen HS, et al. (March 2007). "Mutations in the Kv1.5 channel gene KCNA5 in cardiac arrest patients".Biochemical and Biophysical Research Communications.354 (3):776–782.doi:10.1016/j.bbrc.2007.01.048.PMID17266934.
Crumb WJ, Wible B, Arnold DJ, Payne JP, Brown AM (January 1995). "Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: possible mechanism for terfenadine-associated cardiotoxicity".Molecular Pharmacology.47 (1):181–190.doi:10.1016/S0026-895X(25)08517-7.PMID7838127.
Phromchotikul T, Browne DL, Curran ME, Keating MT, Litt M (September 1993). "Dinucleotide repeat polymorphism at the KCNA5 locus".Human Molecular Genetics.2 (9): 1512.doi:10.1093/hmg/2.9.1512-a.PMID8242092.
Albrecht B, Weber K, Pongs O (1996). "Characterization of a voltage-activated K-channel gene cluster on human chromosome 12p13".Receptors & Channels.3 (3):213–220.PMID8821794.
Lacerda AE, Roy ML, Lewis EW, Rampe D (August 1997). "Interactions of the nonsedating antihistamine loratadine with a Kv1.5-type potassium channel cloned from human heart".Molecular Pharmacology.52 (2):314–322.doi:10.1124/mol.52.2.314.PMID9271355.
Williams CP, Hu N, Shen W, Mashburn AB, Murray KT (August 2002). "Modulation of the human Kv1.5 channel by protein kinase C activation: role of the Kvbeta1.2 subunit".The Journal of Pharmacology and Experimental Therapeutics.302 (2):545–550.doi:10.1124/jpet.102.033357.PMID12130714.S2CID34085749.
